Jay,
Will is absolutely right, IMS is the only company with a good National coverage of pharma companies. As I used to be an analyst in this industry and worked a lot with IMS, I can suggest a few tips on how to reduce the cost of the data:
1) Try looking for their syndicated reports, rather than runs on their databases. Their reports can give you what you need, but would cost you a fraction of the cost of a full market download;
2) If you still ask for a run on their database, ask them to exclude the most recent data point(s): the older data is always cheaper with them; If you ask them to exclude last month's sales, you would save a lot.
3) When talking to them, make sure they understand that this is for academic research. They can give a more foavorable pricing.
As an alternative to IMS, try also Datamonitor. They have a large healthcare practice and do a lot of reports on pharma industry. Their data, however is mostly drawn from public company reports (as far as I know).
VeriSpan might be another option: they have retail pharmacy and hospital data, as IMS does, but with inferior coverage.
If you are interested in Canadian data, talk also to Brogan Inc., a local competitor of IMS.
Good luck with your project!
Alex
________________________________________
From: Business Policy and Strategy List [
BPS-NET@AOMLISTS.PACE.EDU] On Behalf Of Will Mitchell [
will.mitchell@DUKE.EDU]
Sent: Friday, June 12, 2009 3:08 PM
To:
BPS-NET@AOMLISTS.PACE.EDU
Subject: Re: R&D investment in the U.S.pharmaceutical industry
---------------------- Information from the mail header -----------------------
Sender: Business Policy and Strategy List <
BPS-NET@AOMLISTS.PACE.EDU>
Poster: Will Mitchell <
will.mitchell@DUKE.EDU>
Subject: Re: R&D investment in the U.S.pharmaceutical industry
-------------------------------------------------------------------------------
ReCap has some of this information, though only sketchy (recap.com),
though you need a subscription to get in (it is a relatively cheap
subscription, so someone at UBC or SFU may have one).
IMS is the major source, but its data is really expensive.
will
Cui, Victor wrote:
> Is anyone aware of any data sources that disclose R&D investment and firm size of private firms in the U.S.pharmaceutical industry ? Thank you in advance.
>
>
> Victor Cui
> Sauder School of Business
> University of British Columbia
> Vancouver, BC
> V6T 1Z2, Canada
> (604) 822-5876
>
>
>